+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The changing mortality from motor neurone disease and multiple sclerosis in England and Wales and the Republic of Ireland



The changing mortality from motor neurone disease and multiple sclerosis in England and Wales and the Republic of Ireland



Neuroepidemiology 11(4-6): 236-243



A study has been undertaken to ascertain the changes in mortality from motor neurone disease (MND) and from multiple sclerosis (MS) in England and Wales and in the Republic of Ireland. During the 20 years 1968-1987, 16,077 deaths were reported as being primarily due to MND in England and Wales with a male/female ratio of 1.22. There has been an increase in MND deaths from 3,185 in 1968-1972 to 5,241 in 1983-1987. The increase occurred in the death rates in both sexes and in all age groups, but particularly over the age of 65. In contrast, there was no increase in MS deaths and the MS death rates fell below the age of 55 but increased over this age, evidence that MS patients are living longer. A similar but more marked increase in MND mortality, and a considerable fall in MS mortality, occurred in the Republic of Ireland. The increase in MND mortality is not due to an increase in the number of neurologists, as there has been little increase in their numbers. The highest MND mortality was in Social Class IIIN males - skilled non-manual workers.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 041588786

Download citation: RISBibTeXText

PMID: 1291887


Related references

The Changing Mortality from Motor Neurone Disease and Multiple Sclerosis in England and Wales and the Republic of Ireland. Neuroepidemiology 11(4-6): 236-243, 1992

Nutritional advice and treatment by dietitians to patients with amyotrophic lateral sclerosis/motor neurone disease: a survey of current practice in England, Wales, Northern Ireland and Canada. Journal of Human Nutrition and Dietetics 20(1): 3, 2007

Motor neuron disease and multiple sclerosis mortality in Australia, New Zealand and South Africa compared with England and Wales. Journal of Neurology, Neurosurgery, and Psychiatry 56(6): 633-637, 1993

Access to health services in Ireland for people with Multiple Sclerosis and Motor Neurone Disease. Irish Medical Journal 96(7): 200-203, 2003

Trends In Place Of Death, And The Effect Of Death Certificate Classification And Coding Changes, In Parkinsons Disease, Motor Neurone Disease, And Multiple Sclerosis In England: 19932010. Journal of Neurology, Neurosurgery & Psychiatry 83(Suppl 2): A14.2-A14, 2012

Frequency, timing and outcome of gastrostomy tubes for amyotrophic lateral sclerosis/motor neurone disease--a record linkage study from the Scottish Motor Neurone Disease Register. Journal of Neurology 251(7): 813-817, 2004

Lysosomal enzymes in motor neurone disease and multiple sclerosis. Clinica Chimica Acta; International Journal of Clinical Chemistry 47(3): 397-402, 1973

Palliative care in multiple sclerosis and motor neurone disease. British Journal of Hospital Medicine 71(1): 21-25, 2010

Multiple Sclerosis and Motor Neurone Disease: Survival and How Certified after Death. Journal of Epidemiology and Community Health (1979-) 41(1): 14-17, 1987

Health professionals' responses to multiple sclerosis and motor neurone disease. Palliative Medicine 12(5): 383-394, 1998

Health professionals' responses to multiple sclerosis and motor neurone disease. Palliative Medicine 12(5): 383-394, 1998

The competitiveness of business services in the Republic of Ireland, Northern Ireland, Wales, and the South East of England. Environment and Planning A 28(7): 1299-1313, 1996

Lipid studies in the blood and brain in multiple sclerosis and motor neurone disease. Journal of Clinical Pathology 18(5): 641-644, 1965

New drugs and changing mortality from non-infectious disease in England and Wales. British Medical Bulletin 26(3): 191-196, 1970

A comparison of toxicity of serum from multiple sclerosis and motor neurone disease on myelin in vitro. International Archives of Allergy and Applied Immunology 36: Suppl:563, 1969